159 related articles for article (PubMed ID: 34617166)
1. Nanoemulsomes for Enhanced Oral Bioavailability of the Anticancer Phytochemical Andrographolide: Characterization and Pharmacokinetics.
Elsheikh MA; Rizk SA; Elnaggar YSR; Abdallah OY
AAPS PharmSciTech; 2021 Oct; 22(7):246. PubMed ID: 34617166
[TBL] [Abstract][Full Text] [Related]
2. Novel bioemulsomes for baicalin oral lymphatic targeting: development, optimization and pharmacokinetics.
Rizk SA; Elsheikh MA; Elnaggar YS; Abdallah OY
Nanomedicine (Lond); 2021 Sep; 16(22):1983-1998. PubMed ID: 34420422
[No Abstract] [Full Text] [Related]
3. Novel cremochylomicrons for improved oral bioavailability of the antineoplastic phytomedicine berberine chloride: Optimization and pharmacokinetics.
Elsheikh MA; Elnaggar YSR; Hamdy DA; Abdallah OY
Int J Pharm; 2018 Jan; 535(1-2):316-324. PubMed ID: 29138046
[TBL] [Abstract][Full Text] [Related]
4. Repurposing of atorvastatin emulsomes as a topical antifungal agent.
Eita AS; M A Makky A; Anter A; Khalil IA
Drug Deliv; 2022 Dec; 29(1):3414-3431. PubMed ID: 36428290
[TBL] [Abstract][Full Text] [Related]
5. Oral Bioavailability Enhancement and Anti-Fatigue Assessment of the Andrographolide Loaded Solid Dispersion.
Yen CC; Liang YK; Cheng CP; Hsu MC; Wu YT
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260319
[TBL] [Abstract][Full Text] [Related]
6. Bioactive-Chylomicrons for Oral Lymphatic Targeting of Berberine Chloride: Novel Flow-Blockage Assay in Tissue-Based and Caco-2 Cell Line Models.
Elsheikh MA; Elnaggar YSR; Otify DY; Abdallah OY
Pharm Res; 2018 Jan; 35(1):18. PubMed ID: 29305670
[TBL] [Abstract][Full Text] [Related]
7. Engineered chylomicron mimicking carrier emulsome for lymph targeted oral delivery of methotrexate.
Paliwal R; Paliwal SR; Mishra N; Mehta A; Vyas SP
Int J Pharm; 2009 Oct; 380(1-2):181-8. PubMed ID: 19576973
[TBL] [Abstract][Full Text] [Related]
8. Improved bioavailability of orally administered andrographolide from pH-sensitive nanoparticles.
Chellampillai B; Pawar AP
Eur J Drug Metab Pharmacokinet; 2011 Jan; 35(3-4):123-9. PubMed ID: 21302039
[TBL] [Abstract][Full Text] [Related]
9. Preparation of andrographolide-loaded solid lipid nanoparticles and their in vitro and in vivo evaluations: characteristics, release, absorption, transports, pharmacokinetics, and antihyperlipidemic activity.
Yang T; Sheng HH; Feng NP; Wei H; Wang ZT; Wang CH
J Pharm Sci; 2013 Dec; 102(12):4414-25. PubMed ID: 24166599
[TBL] [Abstract][Full Text] [Related]
10. Investigation of 1,2-Dimyristoyl-sn-Glycero-3-Phosphoglycerol-Sodium (DMPG-Na) Lipid with Various Metal Cations in Nanocochleate Preformulation: Application for Andrographolide Oral Delivery in Cancer Therapy.
Ahiwale RJ; Chellampillai B; Pawar AP
AAPS PharmSciTech; 2020 Oct; 21(7):279. PubMed ID: 33037507
[TBL] [Abstract][Full Text] [Related]
11. Poor oral bioavailability of a promising anticancer agent andrographolide is due to extensive metabolism and efflux by P-glycoprotein.
Ye L; Wang T; Tang L; Liu W; Yang Z; Zhou J; Zheng Z; Cai Z; Hu M; Liu Z
J Pharm Sci; 2011 Nov; 100(11):5007-17. PubMed ID: 21721007
[TBL] [Abstract][Full Text] [Related]
12. Lipidic Nano-Sized Emulsomes Potentiates the Cytotoxic and Apoptotic Effects of Raloxifene Hydrochloride in MCF-7 Human Breast Cancer Cells: Factorial Analysis and In Vitro Anti-Tumor Activity Assessment.
Aldawsari HM; Ahmed OAA; Alhakamy NA; Neamatallah T; Fahmy UA; Badr-Eldin SM
Pharmaceutics; 2021 May; 13(6):. PubMed ID: 34073780
[TBL] [Abstract][Full Text] [Related]
13. A matrix dispersion based on phospholipid complex system: preparation, lymphatic transport, and pharmacokinetics.
Li H; Lu S; Luo M; Li X; Liu S; Zhang T
Drug Dev Ind Pharm; 2020 Apr; 46(4):557-565. PubMed ID: 32126844
[TBL] [Abstract][Full Text] [Related]
14. Enhanced oral bioavailability of Tanshinone IIA using lipid nanocapsules: Formulation, in-vitro appraisal and pharmacokinetics.
Ashour AA; Ramadan AA; Abdelmonsif DA; El-Kamel AH
Int J Pharm; 2020 Aug; 586():119598. PubMed ID: 32629068
[TBL] [Abstract][Full Text] [Related]
15. Validity of cycloheximide chylomicron flow blocking method for the evaluation of lymphatic transport of drugs.
Ryšánek P; Grus T; Lukáč P; Kozlík P; Křížek T; Pozniak J; Roušarová J; Královičová J; Kutinová Canová N; Boleslavská T; Bosák J; Štěpánek F; Šíma M; Slanař O
Br J Pharmacol; 2021 Dec; 178(23):4663-4674. PubMed ID: 34365639
[TBL] [Abstract][Full Text] [Related]
16. Solid lipid nanoparticles for delivery of andrographolide across the blood-brain barrier: in vitro and in vivo evaluation.
Graverini G; Piazzini V; Landucci E; Pantano D; Nardiello P; Casamenti F; Pellegrini-Giampietro DE; Bilia AR; Bergonzi MC
Colloids Surf B Biointerfaces; 2018 Jan; 161():302-313. PubMed ID: 29096375
[TBL] [Abstract][Full Text] [Related]
17. Targeting the intestinal lymphatic system: a versatile path for enhanced oral bioavailability of drugs.
Managuli RS; Raut SY; Reddy MS; Mutalik S
Expert Opin Drug Deliv; 2018 Aug; 15(8):787-804. PubMed ID: 30025212
[TBL] [Abstract][Full Text] [Related]
18. Mannosylated-Chitosan-Coated Andrographolide Nanoliposomes for the Treatment of Hepatitis: In Vitro and In Vivo Evaluations.
Metkar SP; Fernandes G; Nikam AN; Soman S; Birangal S; Seetharam RN; Joshi MB; Mutalik S
Membranes (Basel); 2023 Feb; 13(2):. PubMed ID: 36837696
[TBL] [Abstract][Full Text] [Related]
19. Novel self-assembled nano-tubular mixed micelles of Pluronics P123, Pluronic F127 and phosphatidylcholine for oral delivery of nimodipine: In vitro characterization, ex vivo transport and in vivo pharmacokinetic studies.
Basalious EB; Shamma RN
Int J Pharm; 2015 Sep; 493(1-2):347-56. PubMed ID: 26241752
[TBL] [Abstract][Full Text] [Related]
20. Preparation and evaluation of andrographolide-loaded microemulsion.
Du H; Yang X; Li H; Han L; Li X; Dong X; Zhu Q; Ye M; Feng Q; Niu X
J Microencapsul; 2012; 29(7):657-65. PubMed ID: 22533486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
